483
Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.FDA 483 - Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. - April 05, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. in Shijiazhuang, China, was issued a Form 483 with seven observations following an FDA inspection. The firm demonstrated significant deficiencies in laboratory controls, including inadequate stability testing methods and OOS investigations. Additionally, issues were noted with equipment qualification, process validation, drug substance storage conditions, and adherence to cleaning and maintenance procedures.
Open in Dashboard
ID · 8576d1e0-1433-409c-a513-37b36c54d473